GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
3 clinical trials · Sponsor
◉ Watch GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
| Record | Firm | Date |
|---|---|---|
| GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) (NCT04456998) | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2020-11-12 |
| Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension (NCT03926793) | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2020-02-04 |
| Phase 1A Safety Trial of Inhaled PK10571 (GB002) (NCT03473236) | GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2017-09-06 |
Track GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.